Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib Mingxiang LiaoJeri BeltmanJim J. Xiao Review Article Open access 15 September 2022 Pages: 1477 - 1493
Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect Gera NarendraShalki ChoudharyOm Silakari Review Article 30 September 2022 Pages: 1495 - 1517
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug–Disease Interaction Under Different Clinical Conditions Milo GattiFederico Pea Sytematic Review Open access 05 September 2022 Pages: 1519 - 1544
Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates Wan-Yu ChuKarel Allegaertthe ALBINO Study Group Original Research Article Open access 30 August 2022 Pages: 1545 - 1558
Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels Tessa C. C. JaspersCharlotte E. MeijerJeroen V. Koomen Original Research Article Open access 30 August 2022 Pages: 1559 - 1569
Pharmacokinetic Study of Conjugated Equine Estrogens in Healthy Chinese Postmenopausal Women Using a Parallel Two-Column LC–MS/MS Method Meiyun ShiLei YinJingkai Gu Original Research Article 29 September 2022 Pages: 1571 - 1583
Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling Yuanxi ZouJerry NedelmanElin M. Svensson Original Research Article Open access 30 September 2022 Pages: 1585 - 1593
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion Yomna M. NassarNicolas HohmannCharlotte Kloft Original Research Article Open access 04 October 2022 Pages: 1595 - 1607
Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy Michael ThySaik UrienMehdi Oualha Original Research Article 17 October 2022 Pages: 1609 - 1621
Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy Subjects Hamim ZahirJonathan GreenbergFrank LaCreta Original Research Article Open access 20 October 2022 Pages: 1623 - 1639
Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling Maiara Camotti MontanhaFrancesc FabregaMarco Siccardi Correction Open access 16 September 2022 Pages: 1641 - 1641